Advances in Genomic Lab Services Drive Patient-Centered Clinical Trials
David Latto, PhD
How can clinical trial sponsors employ genomic data insights to propel patient-centered drug discovery and development?
David Latto, PhD
David Latto, PhD, is responsible for scientific and technical discussions with pharmaceutical clients and covers Q2 Solutions’ genomic capabilities, including wet-lab methods and assays and development and validation of genomic assays to support clinical research programs. Latto has more than 25 years of experience in the biomarker and precision medicine space and has worked with several high-profile omics-focused technology and services organizations. He earned his PhD in human molecular genetics from the University of Cambridge.